Geron Corp (STU:GON)
€ 1.2445 +0.040 (+3.28%) Market Cap: 799.93 Mil Enterprise Value: 632.79 Mil PE Ratio: 0 PB Ratio: 4.00 GF Score: 45/100

Geron Corp at TD Cowen Healthcare Conference Transcript

Mar 02, 2026 / 06:10PM GMT
Release Date Price: €1.33 (-3.77%)
Tara Bancroft
Cowen and Company LLC - Analyst

All right. We can get started. So hi everyone. I'm Tara Bancroft. I'm one of the Senior Biotech analysts here. And so thank you for coming to TD Cowen's forty-sixth annual healthcare conference. So our next session, we have a fireside chat with Geron, and from Jaron we have the CEO, Harout Semerjian; and the CMO Jo Eid.

So thank you guys both so much for joining us here. It's a bit -- it's a privilege to have you. I thought -- actually, before I get started too, any of you in the audience, if you have a question, please raise your hand, stand up, wave to me, we'll make sure that you get heard too. But, Harout, maybe to start, can you give us some high-level thoughts?

I'd like to ask in a way, since you are now not that new in this role, how your thinking has evolved about priorities at the company? And, how you're going to get to this growth story that you've been talking about since you started.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot